XML 69 R57.htm IDEA: XBRL DOCUMENT v3.22.4
Balance Sheet Components - Accrued and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Balance Sheet Components    
Accrued manufacturing and clinical $ 21,774 $ 30,541
Accrued co-development costs for toripalimab 8,356 1,926
Lease liabilities, current 15,649 12,168
Accrued other 4,318 3,492
Total Accrued and other current liabilities $ 50,097 $ 48,127